- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe Crohn disease (CD)
- Meeting Date: July 2026
Guselkumab – July 2026
- Solution for I.V. infusion 200 mg in 20 mL vial
- Injection 100 mg in 1 mL single use pre-filled pen
- Injection 200 mg in 2 mL single use pre-filled pen
- Injection 100 mg in 1 mL single use pre-filled syringe
- Injection 200 mg in 2 mL single use pre-filled syringe
Public Summary Documents
Last updated
13 November 2026
